Perella Weinberg Guggenheim JP Morgan Credit Suisse
Would appreciate any comments specific to these firms regarding work culture and exit opps.
Trending Content - Investment Banking Forum
Career Resources
WSO Free Modeling Series - Now Open Through
July 31, 2026
9 Free Financial Modeling Lessons
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
+Bonus: Get 27 financial modeling templates in swipe file
+Bonus: Get 27 financial modeling templates in swipe file
High Finance Applications
Guaranteed
Get at least one offer GUARANTEED
- 1:1 support
- 92% success rate
- 2,000+ mentor network
- Unlimited Live bootcamps
- AI for resume + LinkedIn
- Networking automation tools
- HireVue simulation tool
- Full course library
- Private Slack community
- 20hrs of mocks
- + much more...
Healthcare is pretty hot across the board these days, but JPM is one of the top shops on the street if you have to narrow it down.
As someone else mentioned, JPM stands out as the top out of the 4. Not too familiar with CS or PW, but have seen CS on a few things while I haven't seen much PW. I know Guggenheim has been expanding rapidly. They've poached a lot of senior BB people in healthcare and get on some pretty good deals. However, I've read throughout this forum that the exit opps at Guggenheim haven't really caught up with their growth, so to speak.
I'd rank JPM > Gugg ~ CS > PW.
Thread's over two years old now and updated stats just came out for 2017. Two of the three banks mentioned are on the list.
Dealogic revenue ranking for US Healthcare M&A, January-September 2017
JPM $211mm GS $170mm Guggenheim $115mm
JPM by far best on the street. On almost every marquee deal. That said, I would understand if someone considered GS the top, because GS' proportion of M&A deals as % of total HC deal flow is higher than everyone else's. However, if you're really into biotech, be aware that most deals are equity related since biotechs are usually growth companies, etc, etc. JPM does a ton of equity deals in HC.
Gugg staffed up HC by poaching a bunch of Citi HC M&A bankers (Barry Blake's team).
CS is decent in HC, nothing too crazy. PWP will sometimes be on HC deals, I prob wouldn't take it if I had a serious interest in working exclusively in HC.
I appreciate the feedback ladies and gents. In terms of work culture, does anyone have any specific comments. I'm a biopharma specialist and love working hard, but I'm not looking to go to a sweatshop or firm where client/sr. management exposure is limited. Once again, thanks.
How do you guys think HC groups would view recent grads who were pre-med? Lets say they have been to informational presentations with doctors, are familiar with the industry, etc? Would that bring any value to the table at the IB analyst level?
I have this background but haven't tried leveraging it to break in because overall I was a business major and don't want to seem "unfocused"
Just wondering if you see anybody like this, and what you all think. If its too off topic I can post elsewhere, thanks
Have a friend who went premed -> Healthcare IB; it's pretty common. Premed experience as an undergraduate, however, will not add any value to the team - you would need an advanced degree (PhD/MD or maybe masters) in order to reach a level where your scientific knowledge will be a value add. However, your premed experience will be immensely helpful in framing your story and showing interest in the group.
The experience is helpful in crafting a story/relaying interest. Showing you're passionate about a particular industry is always helpful and shows you have interests, but be careful not to come off as HC or bust. The scientific knowledge itself, however, will not really be seen as a value add. You aren't gonna be explaining science shit to your MDs.
Libero dolores cum nulla excepturi tenetur est. Similique molestiae accusantium ex laborum. Aut doloremque distinctio porro praesentium laborum.
Consequatur doloremque non quia accusantium. Inventore et dolor vitae. Aut nam quo labore et porro. Rerum cupiditate at explicabo optio dolorem necessitatibus libero error.
Nobis necessitatibus est facere. Quia provident sint rerum. Et saepe odit sed cupiditate similique.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...